To qualify, you must be 18, have Medicare Part D (prescription drug coverage) and meet the programs clinical criteria: A BMI of 35 or higher A BMI of 30 or higher and one or more of the following conditions: a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension while on at least two blood pressure medications, or chronic kidney disease stage 3a or above A BMI of 27 or higher and one or more of the following conditions a diagnosis of pre-diabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease Those with type 2 diabetes, moderate to severe obstructive sleep apnea, or MASH (fatty liver disease) are ineligible for the Medicare GLP-1 Bridge program
While some individuals achieve better control, others may see minimal change
Based on Omzo's published structure, third-party credential presentation, and HIPAA Privacy Policy publication documentation, the platform appears designed around the legally correct three-entity model
Related: Oprah Winfrey Reveals Unexpected Effect of GLP-1 Medication on Her Health What About Over-The-Counter GLP-1 Patches
Retatrutide also demonstrated positive effects on insulin sensitivity and glycemic control, with nearly three-quarters of prediabetic participants returning to normal blood sugar levels after 48 weeks of treatment [R]
The Why and How for
